[EN] THIOPHENE DERIVATIVES FOR THE TREATMENT OF DISORDERS CAUSED BY IGE<br/>[FR] DÉRIVÉS DE THIOPHÈNE POUR LE TRAITEMENT DE TROUBLES PROVOQUÉS PAR IGE
申请人:UCB BIOPHARMA SRL
公开号:WO2019243550A1
公开(公告)日:2019-12-26
Thiophene derivatives of formula (I) and a pharmaceutically acceptable salt thereof are provided. These compounds have utility for the treatment or prevention of disorders caused by IgE, such as allergy, type 1 hypersensitivity or familiar sinus inflammation.
Studying Products of Hydrazine Interaction with Isothiocyanates by Means of Chromatography and Mass Spectrometry
作者:A. V. Ul’yanov、K. E. Polunin、I. A. Polunina、A. K. Buryak
DOI:10.1134/s0036024421050290
日期:2021.5
compounds in real-time and delayed modes are optimized. The physicochemical characteristics of the sorption of thiosemicarbazides are determined. The decomposition and fragmentation of their metastable protonated molecules are studied. Schemes are proposed for the formation of fragmented and characteristic thiosemicarbazide ions in different modes of ionization.
Combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
申请人:Metabasis Therapeutics, Inc.
公开号:US06756360B1
公开(公告)日:2004-06-29
Pharmaceutical compositions containing an FBPase inhibitor and an insulin sensitizer are provided as well as methods for treating diabetes and diseases responding to increased glycemic control, an improvement in insulin sensitivity, a reduction in insulin levels, or an enhancement of insulin secretion.
Diphenyl ether derivatives and herbicides containing same
申请人:Mitsui Toatsu Chemicals, Inc.
公开号:US04515628A1
公开(公告)日:1985-05-07
Novel diphenyl ether hydrazine derivatives, particularly 2-nitro-5 (nucleus-substituted phenoxy) phenylhydrazine derivatives are provided. They are useful as a selective herbicide having a high herbicidal acitivity and residual efficacy.
dual agonists, which show excellent agonistic activity in PPARalpha/gamma transactivation assay. In particular, (R)-9d was identified as a potent PPARalpha/gamma dual agonist with EC(50)s of 0.377 microM in PPARalpha and 0.136 microM in PPARgamma, respectively. Interestingly, the structure-activityrelationship revealed that the stereochemistry of the identified PPARalpha/gamma dual agonists significantly